Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2026-01-29 @ 5:26 AM
Study NCT ID:
NCT00416520
Status:
COMPLETED
Last Update Posted:
2014-11-04
First Post:
2006-12-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia
Sponsor:
Tanabe Pharma Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MCI-196-E07
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None